Fri, Apr 19, 2024
A A A
Welcome Guest
Free Trial RSS pod
Get FREE trial access to our award winning publications
Alternative Market Briefing

Australian long/short global equity fund returns 10.7% YTD from longs in Japan, U.S. banks and healthcare

Friday, July 24, 2015

amb
Jack Lowenstein
Benedicte Gravrand, Opalesque Geneva:

The Morphic Global Opportunities Fund, a long/short global equity hedge fund, returned 10.77% in H1 2015, outperforming its benchmark (MSCI All Countries World Total Return Net Index in A$) by 1.46% net of fees. It has annualized 26.6% (net) since its August 2012 inception.

The Fund fell 2.44% in June as its benchmark fell 2.75%, with positions in China being the major negative contributors – although China related holdings were positive contributors during the other months.

The fund benefited from its long positions in the Japanese drugstore sector, the U.S. bank sector (as this theme does well when US interest rates are expected to rise) and the U.S. healthcare sector.

In H2 in particular, the Fund enjoyed a tail wind from the weakening of the Australian dollar, and the deliberate under-weight position in Australian equities. The biggest contribution came from stock-picking on the long side, with small gains from long/short pairs trades.

Morphic Asset Management, the Sydney-based fund management firm, commented in their half-yearly report to investors, "it has been a remarkable three years for stock markets and that returns are unlikely to remain as elevated in ......................

To view our full article Click here

Previous Opalesque Exclusives                                  
Previous Other Voices                                               
Access Alternative Market Briefing

 



  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. KKR raises $6.4bn for the largest pan-Asia infrastructure fund[more]

    Laxman Pai, Opalesque Asia: The New York-based global investment firm KKR has raised a record $6.4bn for its second Asia-focused infrastructure fund, underlining investors' continued appetite for private markets. According to a media release from the alternative assets manager, the figure top

  2. Bucking the trend, top hedge fund makes plans for a second SPAC[more]

    From Institutional Investor: SPACs aren't dead. At least not to the folks at Cormorant Asset Management. The life sciences firm, whose hedge fund topped its peers in 2023, is confident it will match the success of its first blank-check company. Last week, the life sciences and biopharma speciali

  3. Benefit Street Partners closes fifth fund on $4.7 billion[more]

    Bailey McCann, Opalesque New York: Benefit Street Partners has closed its fifth flagship direct lending vehicle, BSP Debt Fund V, with $4.7 billion of investable capital across the strategy. Benefit Street invests primarily in privately originated, floating rate, senior secured loans. The fun

  4. 4 hedge fund themes that are working in 2024[more]

    From The Street: A poor earnings report from Tesla (TSLA) has not hurt the indexes on Thursday. The decline in Tesla stock, which is losing its position in the Magnificent Seven pantheon, is more than offset by strong earnings from IBM (IBM) and ServiceNow (NOW) . In addition, the much higher-t

  5. Opalesque Exclusive: A global macro fund eyes opportunities in bonds[more]

    Bailey McCann, Opalesque New York for New Managers: Munich-based ThirdYear Capital rebounded in 2023, following a tough year for global macro. The firm's flagship ART Global Macro strategy finished the year up 1